Product Code: ETC7544230 | Publication Date: Sep 2024 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India Gastrointestinal Stromal Tumor (GIST) market is witnessing steady growth due to increasing awareness, improved diagnostic techniques, and rising incidence of GIST cases in the country. The market is primarily driven by the availability of advanced treatment options such as targeted therapies and surgical interventions. Key players in the Indian GIST market include pharmaceutical companies offering innovative drugs for GIST treatment, as well as healthcare providers specializing in oncology services. The market is also influenced by government initiatives to improve cancer care infrastructure and access to affordable treatment options for patients. With ongoing research and development efforts focused on improving GIST treatment outcomes, the India GIST market is expected to continue its growth trajectory in the coming years.
The India Gastrointestinal Stromal Tumor (GIST) market is witnessing significant growth due to increasing awareness, improved diagnostic techniques, and advancements in targeted therapies. Rising incidence of GIST cases, especially among the elderly population, is driving market expansion. Opportunities lie in the development of personalized treatment options, such as precision medicine and immunotherapy, tailored to individual patient characteristics and genetic profiles. Additionally, collaborations between healthcare providers, pharmaceutical companies, and research institutions are fostering innovation in treatment approaches. The market is also benefiting from government initiatives to improve healthcare infrastructure and access to cancer care services. Overall, the India GIST market presents promising prospects for companies investing in research and development of novel therapies and diagnostic tools.
The India Gastrointestinal Stromal Tumor (GIST) market faces several challenges, including limited awareness about the disease among the general population and healthcare professionals, leading to delayed diagnosis and treatment initiation. Additionally, the high cost of targeted therapy drugs used in GIST treatment poses a barrier for many patients in accessing effective treatment options. There is also a lack of specialized treatment centers and trained healthcare providers in some regions of India, which hinders the delivery of optimal care for GIST patients. Furthermore, the regulatory environment and pricing pressures in the Indian healthcare system can impact the availability and affordability of GIST treatments, further complicating the market landscape for both patients and healthcare providers.
The India Gastrointestinal Stromal Tumor (GIST) market is primarily driven by factors such as increasing prevalence of GIST cases, advancements in diagnostic techniques, rising awareness about early detection and treatment options, and the availability of innovative therapies. The growing adoption of targeted therapies, such as tyrosine kinase inhibitors, for the treatment of GIST has also significantly contributed to market growth. Additionally, the improving healthcare infrastructure, expanding healthcare expenditure, and rising investments in research and development activities aimed at developing novel treatment options for GIST are further fueling market expansion. Overall, the increasing focus on personalized medicine and the emergence of precision oncology approaches are expected to drive the India GIST market in the coming years.
Government policies related to the India Gastrointestinal Stromal Tumor (GIST) market primarily focus on improving access to affordable healthcare services, promoting research and development in the field of oncology, and ensuring the availability of essential medications for GIST treatment. The Indian government has implemented various initiatives such as the National Health Mission (NHM) and the Ayushman Bharat scheme to expand healthcare coverage and provide financial protection to patients. Additionally, regulatory bodies like the Drug Controller General of India (DCGI) regulate the approval and pricing of GIST medications to ensure patient safety and affordability. The government also supports research collaborations between academia and industry to drive innovation in GIST diagnosis and treatment, ultimately aiming to enhance healthcare outcomes for GIST patients in India.
The India Gastrointestinal Stromal Tumor (GIST) market is expected to witness significant growth in the coming years due to increasing awareness, improved diagnostics, and advancements in treatment options. The rising incidence of GIST cases, coupled with the availability of targeted therapies and personalized medicine, is driving market expansion. Additionally, the growing healthcare infrastructure, expanding insurance coverage, and rising healthcare expenditures are expected to further boost market growth. Key players in the market are focusing on developing innovative therapies and expanding their product portfolios to capitalize on the growing demand for effective GIST treatments. Overall, the India GIST market is poised for substantial growth as healthcare providers, pharmaceutical companies, and policymakers collaborate to improve patient outcomes and enhance access to cutting-edge treatments.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Gastrointestinal Stromal Tumor Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Gastrointestinal Stromal Tumor Market Revenues & Volume, 2021 & 2031F |
3.3 India Gastrointestinal Stromal Tumor Market - Industry Life Cycle |
3.4 India Gastrointestinal Stromal Tumor Market - Porter's Five Forces |
3.5 India Gastrointestinal Stromal Tumor Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 India Gastrointestinal Stromal Tumor Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Gastrointestinal Stromal Tumor Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 India Gastrointestinal Stromal Tumor Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Gastrointestinal Stromal Tumor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Gastrointestinal Stromal Tumor Market Trends |
6 India Gastrointestinal Stromal Tumor Market, By Types |
6.1 India Gastrointestinal Stromal Tumor Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Gastrointestinal Stromal Tumor Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Gastrointestinal Stromal Tumor Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Gastrointestinal Stromal Tumor Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 India Gastrointestinal Stromal Tumor Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India Gastrointestinal Stromal Tumor Market Import-Export Trade Statistics |
7.1 India Gastrointestinal Stromal Tumor Market Export to Major Countries |
7.2 India Gastrointestinal Stromal Tumor Market Imports from Major Countries |
8 India Gastrointestinal Stromal Tumor Market Key Performance Indicators |
9 India Gastrointestinal Stromal Tumor Market - Opportunity Assessment |
9.1 India Gastrointestinal Stromal Tumor Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 India Gastrointestinal Stromal Tumor Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Gastrointestinal Stromal Tumor Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 India Gastrointestinal Stromal Tumor Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Gastrointestinal Stromal Tumor Market - Competitive Landscape |
10.1 India Gastrointestinal Stromal Tumor Market Revenue Share, By Companies, 2024 |
10.2 India Gastrointestinal Stromal Tumor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |